Curebase Joins the SCRS Global Impact Partner Program
February 7, 2022
SAN FRANCISCO, Feb. 7, 2022 /PRNewswire/ -- The Society for Clinical Research Sites (SCRS) announced today that Curebase, a company committed to democratizing access to clinical studies, has joined the organization as a Global Impact Partner (GIP). GIPs work closely with the SCRS Leadership Council as strategic partners that set key initiatives for SCRS to advance site performance and sustainability. Becoming a GIP demonstrates Curebase's commitment to develop a comprehensive understanding of the needs of research sites and incorporate site feedback into the development of clinical research software.
"Curebase is working to create a flexible decentralized solution for both patients and sites. Ensuring site voices are heard as the industry develops new solutions is critical. SCRS welcomes Curebase into the Global Impact Partner program and recognizes their commitment to strong site engagement, so the industry can move forward together," commented Sean Soth, Senior Vice President of Strategy & Global Business Partnerships for SCRS.
"Site engagement and access is critical to our mission," said Tom Lemberg, founder and CEO of Curebase. "We are excited to work closely with SCRS as a Global Impact Partner to enable access to clinical studies for any clinician, including independent sites, to advance clinical research."
About The Society for Clinical Research Sites (SCRS)
Founded in 2012, SCRS is a global organization that unifies the voice of the clinical research site community to create greater site sustainability. Representing over 9,500 sites in 47 countries, SCRS membership provides sites with a community dedicated to advocacy, education, mentorship and connectivity. SCRS is an influential voice for sites and an active partner in industry-wide initiatives and dialogues focused on improving the clinical research enterprise. Our Voice. Our Community. Your Success. Join the community.
At Curebase, our mission is to bring quality medical innovations to patients faster and improve human wellbeing through more efficient clinical studies. We are proving that clinical research can be radically accelerated if we empower physicians everywhere to enroll patients in the communities where they live. By applying cutting edge clinical software and remote study management techniques to the problem, we are reinventing clinical trials and research from the ground up.